James Nguyen, MD
Interventional Cardiology · Bradenton, FLNPI 1841441474
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (38.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by Cardinal Health 200 LLC at 35.9% of the total. Reporting peaked in 2019 at $14,197 and has fallen 88.7% since, to $1,607 in 2025.
Across 519 payments — averaging $81.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cardinal Health 200 LLC$15K
- Biotronik Inc.$7K
- Medtronic$6K
- Inari Medical, Inc.$6K
- Boston Scientific$3K
- Abbott$997
- plus $5K from 32 others
Across 7 payments — averaging $615.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Inari Medical, Inc.$4K
What the payments were for
- Consulting fees$16,30438%
- Speaking & faculty fees$4,20010%
- Travel & lodging$9,71223%
- Food & beverage$12,11528%
- Education$2100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cardinal Health 200 LLC | 43 | $15,275 |
| Biotronik Inc. | 24 | $7,126 |
| Medtronic(2 entities) | 55 | $6,013 |
| Inari Medical, Inc. | 36 | $5,552 |
| Boston Scientific | 146 | $2,706 |
| Abbott | 22 | $997 |
| Cardiovascular Systems Inc. | 21 | $842 |
| Penumbra, Inc. | 34 | $682 |
| Cvrx, Inc. | 12 | $323 |
| Abiomed | 16 | $312 |
| W. L. Gore & Associates, Inc. | 15 | $276 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 11 | $267 |
| Biosense Webster, Inc. | 9 | $257 |
| Novartis | 11 | $257 |
| Edwards Lifesciences | 3 | $256 |
| Amgen | 9 | $124 |
| United Therapeutics Corporation | 1 | $123 |
| Novo Nordisk | 5 | $106 |
| Cordis Corporation | 2 | $100 |
| Shockwave Medical, Inc | 4 | $100 |
| Sanofi-aventis U.S. LLC | 5 | $98 |
| Johnson & Johnson | 4 | $86 |
| Pfizer | 3 | $76 |
| Alnylam Pharmaceuticals Inc. | 3 | $73 |
| Intact Vascular, Inc. | 1 | $65 |
| Merck | 3 | $62 |
| Boehringer Ingelheim | 3 | $60 |
| Regeneron Healthcare Solutions, Inc. | 3 | $57 |
| Philips North America LLC | 3 | $54 |
| Scpharmaceuticals Inc. | 2 | $51 |
| Stryker | 2 | $35 |
| Osprey Medical Inc | 1 | $33 |
| AstraZeneca | 2 | $31 |
| Cardiva Medical, Inc. | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $16 |
| Aquestive Therapeutics, Inc. | 1 | $12 |
| Bardy Diagnostics, Inc. | 1 | $10 |
| G Medical Diagnostic Services, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CT THROMBECTOMY SYSTEM KIT$7,272
- Orsiro$4,774
- Pulsar$4,774
- Astron; Pulsar; AstronPulsar$4,774
- PK Papyrus$4,774
- CoreValve Evolut$4,153
- Passeo$3,000
- Tryton Side Branch Stent$1,954
- PRO-Kinetic Energy$1,774
- FLOWTRIEVER CATHETER, S$1,272
- GENERAL - THERAPIES$684
- FlowTriever$486
- ClotTriever$486
- EluNIR Radaforolimus Eluting Coronary Stent System$470
- Peripheral Orbital Atherectomy System$375
- Coronary Orbital Atherectomy System$375
- CardioMEMS HF System$297
- Orsiro Mission$265
- MitraClip$264
- Indigo System$256
How this compares
$42,541 in reported general payments places this provider in the 85th percentile of 623 interventional cardiology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 254 | $279,435 |
| XareltoRivaroxaban | 189 | $235,435 |
| OzempicSemaglutide | 122 | $142,598 |
| EntrestoSacubitril/Valsartan | 126 | $108,965 |
| Repatha SureclickEvolocumab | 22 | $25,012 |
| BrilintaTicagrelor | 21 | $13,811 |
| ClopidogrelClopidogrel Bisulfate | 781 | $8,806 |
| Midodrine Hcl | 74 | $7,004 |
| Valsartan | 175 | $3,962 |
| Nifedipine ErNifedipine | 107 | $3,954 |
| Atorvastatin Calcium | 403 | $3,394 |
| Ranolazine ErRanolazine | 26 | $3,361 |
| Metoprolol Succinate | 330 | $3,357 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 13 | $2,385 |
| Diltiazem 24hr Er (La)Diltiazem Hcl | 31 | $2,328 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $76 | $279,435254 claims |
| Johnson & JohnsonXarelto | $86 | $235,435189 claims |
| Novo NordiskOzempic | $106 | $142,598122 claims |
| NovartisEntresto | $257 | $108,965126 claims |
| AstraZenecaBrilinta | $31 | $13,81121 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 623 interventional cardiology providers in Florida.
Other interventional cardiology in Bradenton
- Santhosh MathewsBradenton$1.4M
- Arthur LeeGainesville$1.8M
- Siddharth WayangankarJacksonville$1.2M
- Patrick CambierTrinity$901K
- Zahid AminOrlando$635K
- Rohit AminPensacola$560K
- Eduardo de MarchenaMiami$498K
- Dominick AngiolilloJacksonville$387K
- Miguel DiazHialeah$383K
- Douglas EbersoleLakeland$373K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.